Cystic Fibrosis  >>  ciprofloxacin (Q3939)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT00930982 / 2009-009869-34: Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Completed
2
124
US, Europe, RoW
Ciprofloxacin (Cipro, BAYQ3939), Placebo
Bayer, Novartis
Bronchiectasis
09/10
09/10
NCT00645788 / 2008-008314-40: Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis

Completed
2
288
US, Canada, Europe, RoW
Ciprofloxacin (Cipro Inhale, BAYQ3939), Placebo
Bayer, Novartis
Cystic Fibrosis
01/11
01/11

Download Options